Obermatt
See Similar Stocks →

Rapid Micro Biosystems

NAQ:RPID · US75340L1044
Life Sciences Tools & ServicesSmall

360

32
Profit price43
Owner Earnings Yield1
Dividend Yield1
Price/Sales63
EV / Gross Profit1
Price/Book95
Return on Capital1
Cash Return on Capital1
Return on Equity4
EBIT Margin8
Gross Profitability4
Accruals97
Owner Earnings Margin8
Sales growth86
Profit growth21
Reinvestment74
Price momentum13
Debt load62
Refinancing71
Debt Payback1
Liquidity10
Analyst ratings100
Opinion Changes50
Price Target Upside98
Market mood10
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Rapid Micro Biosystems doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2006
Employees146
Websiterapidmicrobio.com
ISINUS75340L1044
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
GeneticsBiomedical EngineeringHealth DiagnosticsImage RecognitionIndustrial AutomationEnvironment, Health and Safety (EH&S)Process AutomationVaccinesBiotechnologyManufacturingPharmaceutical

Description

Rapid Micro Biosystems, Inc. operates as a life sciences technology company. The company provides mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, such as biologics, cell…

Analysis

Weak and unloved

Rapid Micro Biosystems, Inc. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 6/20 on our value-creation score: not creating value. Analysts lean positive.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
21
2023202420252026

All-time high

98

Jan 2024

All-time low

13

Mar 2026

Average rank

57

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
63
34
91
36
Price/Earnings
67
94
94
42
Price/Book
95
62
94
100
Dividend Yield
1
1
1
1
Value (overall)
87
41
90
67

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Rapid Micro Biosystems with its peers
Maravai LifeSciences Holdings
NSQ:MRVI
35
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Mesa Laboratories
NSQ:MLAB
69
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Avantor
NYQ:AVTR
13
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
Azenta
NSQ:AZTA
35
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
Full Stock Analysis →
Haemonetics
NYQ:HAE
46
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Alpha Teknova
NMQ:TKNO
32
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →